Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery-Reference-Cited by-同舟云学术

Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery

Published:2024-02-06 Issue:5 Volume:31 Page:2902-2912
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Ando Yohei,Dbouk Mohamad,Blackford Amanda L.,Yoshida Takeichi,Saba Helena,Abou Diwan Elizabeth,Yoshida Kanako,Sokoll Lori,Eshleman James R,Burkhart Richard,He Jin,Goggins Michael

Funder

Division of Cancer Prevention, National Cancer Institute

Stand Up To Cancer

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-14942-5.pdf

Reference39 articles.

1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48. https://doi.org/10.3322/caac.21763.

2. Belfiori G, Crippa S, Francesca A, et al. Long-term survivors after upfront resection for pancreatic ductal adenocarcinoma: an actual 5-year analysis of disease-specific and post-recurrence survival. Ann Surg Oncol. 2021;28:8249–60. https://doi.org/10.1245/s10434-10021-10401-10437.

3. Rangelova E, Wefer A, Persson S, et al. Surgery improves survival after neoadjuvant therapy for borderline and locally advanced pancreatic cancer: a single-institution experience. Ann Surg. 2021;273:579–86. https://doi.org/10.1097/SLA.0000000000003301.

4. Versteijne E, van Dam JL, Suker M, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial. J Clin Oncol. 2022;40:1220–30. https://doi.org/10.1200/JCO.1221.02233.

5. Blinn P, Shridhar R, Maramara T, Huston J, Meredith K. Multi-agent neoadjuvant chemotherapy improves response and survival in patients with resectable pancreatic cancer. J Gastrointest Oncol. 2020;11:1078–89. https://doi.org/10.21037/jgo.22019.21012.21003.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1;BMC Cancer;2024-07-04

2. ASO Author Reflections: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome after Pancreatic Cancer Surgery;Annals of Surgical Oncology;2024-01-27